KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Current Deferred Revenue (2017 - 2020)

Novartis Ag's Current Deferred Revenue history spans 4 years, with the latest figure at $56.0 million for Q4 2020.

  • On a quarterly basis, Current Deferred Revenue fell 50.88% to $56.0 million in Q4 2020 year-over-year; TTM through Dec 2020 was $56.0 million, a 50.88% decrease, with the full-year FY2020 number at $56.0 million, down 50.88% from a year prior.
  • Current Deferred Revenue hit $56.0 million in Q4 2020 for Novartis Ag, down from $114.0 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for NVS hit a ceiling of $305.0 million in Q4 2017 and a floor of $56.0 million in Q4 2020.
  • Historically, Current Deferred Revenue has averaged $177.8 million across 4 years, with a median of $175.0 million in 2018.
  • Biggest five-year swings in Current Deferred Revenue: decreased 22.62% in 2018 and later plummeted 51.69% in 2019.
  • Tracing NVS's Current Deferred Revenue over 4 years: stood at $305.0 million in 2017, then dropped by 22.62% to $236.0 million in 2018, then plummeted by 51.69% to $114.0 million in 2019, then plummeted by 50.88% to $56.0 million in 2020.
  • Business Quant data shows Current Deferred Revenue for NVS at $56.0 million in Q4 2020, $114.0 million in Q4 2019, and $236.0 million in Q4 2018.